HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer

Published:2019-09-02 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Guo Jianying,Li Xiao,Zhang Wenhao,Chen Yuling,Zhu Songbiao,Chen Liang,Xu Renhua,Lv Yang,Wu Di,Guo Mingzhou,Liu Xiaohui,Lu Weiguo,Deng Haiteng

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-48992-7.pdf

Reference43 articles.

1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 68, 394–424, https://doi.org/10.3322/caac.21492 (2018).

2. Hartnett, J., Thom, B. & Kline, N. Caregiver Burden in End-Stage Ovarian Cancer. Clinical journal of oncology nursing 20, 169–173, https://doi.org/10.1188/16.cjon.169-173 (2016).

3. Pignata, S. et al. Chemotherapy in epithelial ovarian cancer. Cancer Lett 303, 73–83, https://doi.org/10.1016/j.canlet.2011.01.026 (2011).

4. Chu, C. S., Kim, S. H., June, C. H. & Coukos, G. Immunotherapy opportunities in ovarian cancer. Expert review of anticancer therapy 8, 243–257, https://doi.org/10.1586/14737140.8.2.243 (2008).

5. Zhang, H. et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. Cell 166, 755–765, https://doi.org/10.1016/j.cell.2016.05.069 (2016).

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tubeimoside-I, an inhibitor of HSPD1, enhances cytotoxicity of oxaliplatin by activating ER stress and MAPK signaling pathways in colorectal cancer;Journal of Ethnopharmacology;2025-01

2. LARP1, an RNA-binding protein, participates in ovarian cancer cell survival by regulating mitochondrial oxidative phosphorylation in response to the influence of the PI3K/mTOR pathway;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

3. Unveiling the impact of SUMOylation at K298 site of heat shock factor 1 on glioblastoma malignant progression;Neoplasia;2024-11

4. Clinicopathologic significance of heat shock protein 60 as a survival predictor in breast carcinoma;Frontiers in Oncology;2024-08-19

5. Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation;Biomolecules;2024-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3